GDF15 and Alzheimer disease: We measured the levels of GDF15, FGF21, and HN in 569 plasma samples from T2D patients, with (T2DC) or without (T2DnC) complications, AD patients, healthy age-matched controls (HC), and centenarians’ offspring (OFF), see Table 1.